Imidazolidinone compounds useful as beta-secretase inhibitors for the treatment of Alzheimer's disease

Details for Australian Patent Application No. 2006315817 (hide)

Owner Merck & Co., Inc.

Inventors Rittle, Kenneth E.; Bondiskey, Phung Le; Barrow, James C.

Agent Spruson & Ferguson

Pub. Number AU-A-2006315817

PCT Pub. Number WO2007/058862

Priority 60/737,294 16.11.05 US

Filing date 10 November 2006

Wipo publication date 24 May 2007

International Classifications

C07D 403/00 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Event Publications

8 May 2008 PCT application entered the National Phase

  PCT publication WO2007/058862 Priority application(s): WO2007/058862

2 December 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006315818-System and method for information retrieval from object collections with complex interrelationships

2006315812-Balloon-expandable, self-expanding, vascular prosthesis connecting stent